자동 미생물학 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 자동화 유형별, 용도별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Automated Microbiology Market Growth & Trends:

The global automated microbiology market size is anticipated to reach USD 13.73 billion by 2030 and is anticipated to expand at a CAGR of 10.69% from 2025 to 2030, according to a new report by Grand View Research, Inc. The global automated microbiology market is expected to grow over the forecast period owing to the increasing prevalence of pathogen-induced diseases.

In recent years, the identification of pathogens with the help of automated microbiology has generated huge momentum, as it helps in the early detection of various infectious agents such as parasites, viroid, fungi, prion, bacterium, and viruses. These agents cause severe diseases like rubella, ebola, chickenpox, measles, mumps, influenza, and smallpox. Automated microbiology has gained importance as a result of outbreaks of new diseases as a consequence of adapting and mutating bacteria. The ability to promptly respond to the increasing demand for public health lies in offering accurate, better, and rapid identification of diseases and causative pathogens.

Rapid technological advancements are also boosting the growth of this market. For instance, the STEC test by BioControl Systems helps in the detection of non-O157 serotypes of E.coli with the help of molecular and food microbiology technology and BacT/ALERT 3D microbial detection system introduced by bioMeriux. As compared to other microbial detection systems, automated microbiology comes along with advantages such as early detection and an easy access system.

Recent industry developments underscore the market's dynamic nature. Companies are increasingly integrating artificial intelligence and machine learning into automated microbiology systems to enhance diagnostic accuracy and predict antimicrobial resistance patterns. Additionally, there's a notable shift towards molecular diagnostics, including techniques like polymerase chain reaction (PCR) and nucleic acid sequencing, offering rapid and specific microorganism detection. The COVID-19 pandemic has further accelerated the adoption of these automated solutions, highlighting their crucial role in scaling up testing capacities and reducing diagnostic turnaround times.

Automated Microbiology Market Report Highlights:

• Based on product, reagents & kits segment dominated the market in 2024 owing to the growing demand for rapid and accurate microbial testing is driving the adoption of high-quality reagents and kits in automated microbiology. Advancements in molecular diagnostics, increasing antimicrobial resistance, and stringent regulatory requirements are further fueling market growth.
• Based on automation type, the fully automated segment dominated the market with the highest revenue share in 2024. The push for higher efficiency, reduced human errors, and faster turnaround times in microbial testing is accelerating the adoption of fully automated microbiology systems.
• Based on application, clinical diagnostics dominated the market with highest revenue share of 50.83% in 2024 and is expected to grow at a significant CAGR over the forecast period.
• Based on end use, the hospitals and diagnostic laboratories segment dominated the market with the highest revenue share in 2024, driven by the growing focus on infection control, antimicrobial stewardship, and cost-effective healthcare solutions is further driving market expansion in this segment.
• Based on region, the North America region dominated the automated microbiology market with a share of 41.29% in 2024 owing to factors such as the significant investments in research and development, coupled with the presence of key market players such as BD, Thermo Fisher Scientific, and bioMerieux, further propel market growth in North America.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Automation Type
  • 1.1.3. Application
  • 1.1.4. End Use
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Automated Microbiology Market Variables and Trends

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Industry Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Automated Microbiology: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Automated Microbiology Market: Product Movement Analysis
• 4.3. Automated Microbiology Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Instruments
  • 4.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.2. Automated Microbial Identification Systems
    • 4.4.2.1. Automated Microbial Identification Systems market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.3. Automated Blood Culture Systems
    • 4.4.3.1. Automated Blood Culture Systems market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.4. Automated Colony Counters
    • 4.4.4.1. Automated Colony Counters market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.5. Automated Sample Preparation Systems
    • 4.4.5.1. Automated Sample Preparation Systems market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.6. Automated Antibiotic Susceptibility Testing (AST) Systems
    • 4.4.6.1. Automated Antibiotic Susceptibility Testing (AST) Systems market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.7. Other Instruments
    • 4.4.7.1. Other Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Reagents & Kits
  • 4.5.1. Reagents & Kits market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5.2. Culture Media
    • 4.5.2.1. Culture Media market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5.3. Stains & Dyes
    • 4.5.3.1. Stains & Dyes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5.4. Assay Kits & Panels
    • 4.5.4.1. Assay Kits & Panels market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5.5. Other
    • 4.5.5.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.6. Software
  • 4.6.1. Software market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Automated Microbiology: Automation Type Estimates & Trend Analysis

• 5.1. Assay Type Segment Dashboard
• 5.2. Automated Microbiology Market: Automation Type Movement Analysis
• 5.3. Automated Microbiology Market Size & Trend Analysis, by Automation Type, 2018 to 2030 (USD Million)
• 5.4. Fully Automated
  • 5.4.1. Fully automated market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. Semi-Automated
  • 5.5.1. Semi-automated market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Automated Microbiology: Application Estimates & Trend Analysis

• 6.1. Application Segment Dashboard
• 6.2. Automated Microbiology Market: Application Movement Analysis
• 6.3. Automated Microbiology Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Biopharmaceutical Production
  • 6.4.1. Biopharmaceutical production market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Clinical Diagnostics
  • 6.5.1. Clinical diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.6. Environmental & Water Testing
  • 6.6.1. Environmental & water testing market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.7. Food & Beverage Testing
  • 6.7.1. Food & beverage testing market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.8. Other Applications
  • 6.8.1. Other applications market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Automated Microbiology: End Use Estimates & Trend Analysis

• 7.1. Application Segment Dashboard
• 7.2. Automated Microbiology Market: End Use Movement Analysis
• 7.3. Automated Microbiology Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Pharmaceutical & Biotechnology Companies
  • 7.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.5. Hospitals & Diagnostic Laboratories
  • 7.5.1. Hospitals & diagnostic laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.6. Academic & Research Institutes
  • 7.6.1. Academic & research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.7. Other End Use
  • 7.7.1. Other end use market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Automated Microbiology Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Dashboard
• 8.2. Regional Market Share Analysis, 2024 & 2030
• 8.3. Automated Microbiology Market by Region: Key Takeaways
• 8.4. North America
  • 8.4.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 8.5. Europe
  • 8.5.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5.7. Sweden
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5.8. Norway
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competitive Scenario
    • 8.5.8.3. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5.9. Denmark
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competitive Scenario
    • 8.5.9.3. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6.6. Thailand
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Scenario
    • 8.6.6.3. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6.7. South Korea
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Scenario
    • 8.6.7.3. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 8.8. MEA
  • 8.8.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.8.2. Saudi Arabia
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competitive Scenario
    • 8.8.2.3. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.8.3. South Africa
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competitive Scenario
    • 8.8.3.3. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competitive Scenario
    • 8.8.4.3. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competitive Scenario
    • 8.8.5.3. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

• 9.1. Participant Categorization
• 9.2. Company Market Position Analysis, 2024
• 9.3. Participant Overview
  • 9.3.1. BD
    • 9.3.1.1. Company overview
    • 9.3.1.2. Financial performance
    • 9.3.1.3. Product benchmarking
    • 9.3.1.4. Strategic initiatives
  • 9.3.2. QIAGEN
    • 9.3.2.1. Company overview
    • 9.3.2.2. Financial performance
    • 9.3.2.3. Product benchmarking
    • 9.3.2.4. Strategic initiatives
  • 9.3.3. Thermo Fisher Scientific Inc.
    • 9.3.3.1. Company overview
    • 9.3.3.2. Financial performance
    • 9.3.3.3. Product benchmarking
    • 9.3.3.4. Strategic initiatives
  • 9.3.4. Agilent Technologies, Inc.
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Danaher
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Merck KGaA
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. bioMerieux
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Abbott
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. DiaSorin S.p.A.
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. BioRad Laboratories, Inc.
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives